enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Pfizer raises full-year guidance by $1.5 billion amid ... - AOL

   www.aol.com/finance/pfizer-raises-full-guidance...

   Pipeline growth. The company continues to gain drug approvals and advance products through its pipeline, but so far, none have wowed investors. The company's RSV vaccine is a seasonal product ...

3. Why I'm Considering Leaning Heavily Into Pfizer - AOL

   www.aol.com/why-im-considering-leaning-heavily...

   The company faces headwinds from declining COVID-19 product sales and skepticism surrounding its recent acquisition spree. ... Attractive valuation with pipeline potential. Pfizer has over 100 ...

4. Pfizer Eyes $20 Billion Revenue From Acquisitions Amid ... - AOL

   www.aol.com/pfizer-eyes-20-billion-revenue...

   Additionally, the company is counting on revenues from products already launched and others in the pipeline. This is where the gap lies between Pfizer’s outlook and market expectations.

5. Prediction: This $43 Billion Bet Will Help Pfizer Stock Take ...

   www.aol.com/prediction-43-billion-bet-help...

   On top of this, some of Pfizer's blockbuster products are losing exclusivity later this decade, and this will weigh on revenue. ... The Seagen acquisition also brought Pfizer a strong ADC pipeline ...

6. Pfizer - Wikipedia

   en.wikipedia.org/wiki/Pfizer

   Pfizer was founded in 1849 as "Charles Pfizer & Company" by Charles Pfizer and Charles F. Erhart, [5] two cousins who had immigrated to the United States from Ludwigsburg, Germany. The business produced chemical compounds, and was headquartered on Bartlett Street [ 6 ] in Williamsburgh, New York where they produced an antiparasitic called ...

7. Is Pfizer the Best Dividend Stock for You? - AOL

   www.aol.com/finance/pfizer-best-dividend-stock...

   Source: Pfizer Oncology Innovation Day presentation. Pfizer believes just 35% of its 2030 oncology revenue will come from today's products, meaning the pipeline should do a lot of heavy lifting as ...

8. Pfizer–BioNTech COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Pfizer–BioNTech_COVID-19...

   The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.

9. Seagen acquisition will give Pfizer 'anchor asset' Wall ... - AOL

   www.aol.com/finance/seagen-acquisition-pfizer...

   Pfizer beat earnings expectations, but Wall Street is still waiting to see how it pulls out of waning COVID demand and boosts its pipeline with stronger assets to plug a patent cliff at the end of ...